COLON CANCER
Clinical trials for COLON CANCER explained in plain language.
Never miss a new study
Get alerted when new COLON CANCER trials appear
Sign up with your email to follow new studies for COLON CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets tough cancers with KRAS mutation
Disease control OngoingThis early-stage study tests a new drug, HBI-2438, in people with advanced cancers (like lung, colon, or pancreatic) that have a specific genetic change called KRAS G12C. The main goals are to find the safest dose and understand how the drug moves through the body. About 44 adult…
Matched conditions: COLON CANCER
Phase: PHASE1 • Sponsor: HUYABIO International, LLC. • Aim: Disease control
Last updated Apr 29, 2026 00:20 UTC
-
Gut bacteria boost after cancer surgery: new trial tests postbiotics
Disease control ENROLLING_BY_INVITATIONThis study tests whether taking postbiotic supplements after colon cancer surgery can help restore the natural balance of gut bacteria, which is often disrupted by the procedure. Researchers will compare changes in gut bacteria diversity between a group taking postbiotics and a g…
Matched conditions: COLON CANCER
Phase: NA • Sponsor: University of South Florida • Aim: Disease control
Last updated Apr 29, 2026 00:20 UTC
-
Green tea extract tested to stop colon cancer return
Prevention OngoingThis study looks at whether a compound found in green tea, called EGCG, can help prevent colon cancer from returning after surgery. About 51 people who had colon cancer removed will take EGCG or a placebo. Researchers will check for changes in DNA markers linked to cancer risk.
Matched conditions: COLON CANCER
Phase: EARLY_PHASE1 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Prevention
Last updated Apr 29, 2026 00:21 UTC